Priscila Arbex is the Director of Clinical Affairs currently working for GX Sciences, managing the company’s business growth strategy, evaluating new commercial opportunities, and managing clinical affairs. Dr. Arbex acquired her degree in Nutrition at President Antônio Carlos University (2004-2008), where she developed technical and clinical practice skills in collaboration with hospitals and private clinics. She developed her Master in Nutrition Science from the Federal University of Viçosa (2013-2015), with the title: the potential of extruded sorghum flour (Sorghum Bicolor L.) to modulate adiposity, oxidative stress and inflammation in obese rats fed a high-fat diet. She has a Specialization in Sports Training Science from the Federal University of Juiz de Fora (2010-2012). In 2018 and 2021, she acquired two specializations in the Modulation of Intestinal Microbiome from the Murilo Pereira Institute, focused on conditions related to the immune system and metabolic pathways from the intestinal environment and epigenetics. Dr. Arbex acquired her Ph.D. (2017- 2020) as a researcher in the Department of Health Sciences and Technology in the Nutrition, Metabolism, and Epigenetics laboratory at the Zurich Federal Institute of Technology, Switzerland / ETHz (ETH Zurich) in the area of the ketogenic diet adipocytes and e, epigenetics. In her doctoral thesis, she worked with high fat-fructose diets, microbiome, energy metabolism, and epigenetics using biomolecular research methods. She believes that her academic career is part of her journey to improve her clinical practice. In this sense, she has worked as a clinical nutritionist focused on nutrigenomics and as a professor for various organizations for 10+ years. In 2018 & 2019, as a professor, she taught Dietotherapy in Obesity and Plurimetabolic Syndrome, Biochemistry of Nutrition, Physiology, Pathophysiology, and Etiopathogenesis in liver diseases and Intestine. As a clinical nutritionist, over the past 12 years, she treated and followed up with patients with conditions such as obesity, metabolic syndrome, mood disorders, and severe diseases related to the gastrointestinal tract, mainly associated with the microbiome. Her experience has shown that each individual is unique, and personalized diet and supplementation are crucial to success.